Clinical trial protocol1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer
作者
Stephanie L. Wethington,Payal D. Shah,Lainie P. Martin,János L. Tanyi,Nawar Latif,Mark A. Morgan,Drew A. Torigian,Diego Rodriguez,Simon A. Smith,Emma Dean,Susan M. Domchek,Ronny Drapkin,Ie‐Ming Shih,Eric J. Brown,Wei‐Ting Hwang,Deborah K. Armstrong,Stéphanie Gaillard,Robert Giuntoli,Fiona Simpkins
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
无极微光
Copyright
OK
乐空思
Nole
健壮的书桃
cdercder
yjh123
斯文钢笔
GingerF
sagitar
微笑谷雪
学术文献互助
arniu2008
行走的荷尔蒙
初景
科研狗
Criminology34
殷勤的紫槐
皖公网安备34019202002308
